Which blood panels to monitor during peptide use. IGF-1, metabolic panels, inflammatory markers, and optimal testing frequency.
Before starting any peptide protocol, obtain comprehensive baseline bloodwork. This is your reference point for monitoring changes and ensuring safety.
Re-test the same panels at 8 weeks into your protocol. This gives enough time for changes to manifest while catching any adverse trends early.
After the initial 8-week check, test every 12 weeks (quarterly) for the duration of your protocol. More frequent testing if any markers are out of range.
Compare each result to YOUR baseline, not just reference ranges. A value within range but dramatically different from your baseline warrants attention.
If markers trend unfavorably, reduce dose or discontinue the responsible peptide. Resume testing 4-6 weeks after any protocol change to confirm correction.
Complete Metabolic Panel (CMP): liver enzymes (AST, ALT), kidney function (BUN, creatinine), electrolytes, glucose. Complete Blood Count (CBC): red/white blood cells, platelets. Lipid Panel: total cholesterol, LDL, HDL, triglycerides. Hormone Panel: IGF-1, GH, testosterone (free and total), thyroid (TSH, free T3, free T4). Inflammatory Markers: CRP, ESR, homocysteine.
GH Secretagogues: IGF-1 is the primary marker — aim for 200-300 ng/dL. Watch fasting glucose as GH can impair insulin sensitivity. GLP-1 Agonists: monitor HbA1c, fasting insulin, lipase/amylase (pancreatic safety). Immune Peptides: CBC with differential, immunoglobulin levels. BPC-157/TB-500: standard CMP is sufficient for safety monitoring.
Many direct-to-consumer lab services offer comprehensive panels without a doctor's order. Look for panels specifically designed for hormone optimization or anti-aging protocols, as they include the relevant markers.
Disclaimer: This guide is for educational purposes only. Always follow sterile procedures and consult a healthcare provider.